Delcath Systems Inc (DCTH) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Delcath Systems Inc   (NASDAQ: DCTH)


Delcath Systems Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Delcath Systems Inc 's ROA in the second quarter of 2026?
Delcath Systems Inc achieved a return on average assets (ROA) of 0.42 % in its second quarter of 2026, this is above DCTH's average return on assets of -119.89%.
Delcath Systems Inc assets over the 12 months ending in its second quarter of 2026 are valued at $127 million

ROA fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

However, within the Healthcare sector 206 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 2024 to 2439.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 17.23 % 43.6 % 62.4 % 302.89 % 256.1 %
Y / Y Net Income Change -1.08 % - - -55.47 % -
Net Income (TTM) in million 1 1 3 1 2
Return On Assets (TTM) 0.42 % 0.46 % 2.4 % 1.19 % 2.89 %
DCTH's Total Ranking # 2439 # 2024 # 2102 # 1608 # 3734
Total Assets (TTM) in million 137 124 123 123 117
Seq. Total Assets Change 10.56 % 1.01 % -0.51 % 5.52 % 35.43 %
Seq. Net Income Change - - - -69.23 % 152.29 %



Return On Assets Company Ranking
Within: No.
Industry # 67
Sector # 207
Overall # 2434

Return On Assets Statistics
High Average Low
2.86 %
-119.89 %
-438.18 %
  (Mar 31 2019)



  News about Delcath Systems Inc Return on Assets ROA

Delcath Systems Driving Innovation in Liver Cancer Care Amid Strategic Workforce Expansion,

Delcath Systems, Inc.: Advancements in Liver Cancer Treatment and Strategic Employment Inducements Delcath Systems, Inc. (NASDAQ: DCTH), based in Queensbury, New York, is carving a significant niche in the interventional oncology field, particularly focused on therapies targeting primary and metastatic cancers of the liver. Recent announcements from the company highlight its strategic growth initiatives and substantive research developments pertinent to liver-directed cancer treatments.In a recent disclosure, Delcath Systems confirmed the granting of three equity awards as inducements to attract key personnel who commenced employment in August 2024, following approval from the company’s Compensation Committee. The total grants provided the eligible individuals the right to purchase an aggregate of 46,000 shares. This move aligns with Nasdaq Listing Rule 5635(c)(4), emphasizing Delcath s commitment to enhancing its workforce with skilled professionals to further its business s within the oncology sector.




Financial Statements
Delcath Systems Inc 's Assets $ 137 million DCTH's Balance sheet
Delcath Systems Inc 's Income $ 3 million Quarterly DCTH's Income Statement
DCTH's Income by Division See DCTH's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 62.4 % 96.18 % 119.09 % -45.92 % -3.53 %
Total Assets in million 123 76 39 18 33
Y / Y Net Income Change - - - - -
Net Income in million 3 -26 -48 -37 -26
Annual Return On Assets 2.2 % -34.93 % -123.81 % -207.7 % -78.92 %




Comment on DCTH's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 2.2 % compared to prior year, due to annual net income growth of % to $2.70 million, while value of Delcath Systems Inc 's overall assets grew just by 62.4 % to $122.70 million, compared to $122.70 a year before.


More Return On Assets Ratios
DCTH's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DCTH's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DCTH's Competitors
Subscribers only: Roa for Delcath Systems Inc 's Suppliers
Subscribers only: Return On Assets for DCTH's Customers

You may also want to know
DCTH's Roi DCTH's Inventory Turnover Ratio DCTH's Growth Rates DCTH's Dividend Comparisons
DCTH's Profitability Ratios DCTH's Asset Turnover Ratio DCTH's Dividend Growth
DCTH's Roe DCTH's Valuation Ratios DCTH's Financial Strength Ratios DCTH's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Waters Corporation  1.12 %
Cormedix Inc   1.11 %
Warby Parker Inc   1.05 %
Surgery Partners Inc   1.02 %
Staar Surgical Co  0.84 %
Biomarin Pharmaceutical Inc  0.82 %
Icu Medical Inc  0.75 %
Lifemd Inc   0.65 %
Radnet Inc   0.50 %
Delcath Systems Inc   0.42 %
Talkspace Inc   0.14 %
Champions Oncology Inc   0.13 %
Denali Therapeutics Inc   0.09 %


Date modified: 2026-09-08T17:23:35+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.